Immune Checkpoint Inhibitors-Associated Diabetes and Ketoacidosis Were Found in FDA Adverse Event Reporting System: A Real-World Evidence Database Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune Checkpoint Inhibitors-Associated Diabetes and Ketoacidosis Were Found in FDA Adverse Event Reporting System: A Real-World Evidence Database Study

Published:2024-09 Issue:9 Volume:30 Page:887-892
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Han Meifen,Jiang Lin,Zhao Bin^ORCID,Liu Xiaojun,Yang Changqing,Chen Wei

Publisher

Elsevier BV

Reference33 articles.

1. A snapshot of the PD-1/PD-L1 pathway;Ghosh;J. Cancer,2021

2. Prognostic role of immune checkpoint regulators in cholangiocarcinoma: a pilot study;Cao;J. Clin. Med,2021

3. Reinvigorating exhausted CD8(+) cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy;Hossain;Med. Res. Rev,2021

4. Anti-PD-1 and anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations;Seidel;Front. Oncol,2018

5. Diabetic ketoacidosis secondary to new onset type 1 diabetes mellitus related to pembrolizumab therapy;Hernandez;Cureus,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP